Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upo...
Antigen presentation by MHC-II proteins in the thymus is central to selection of CD4 T cells, but an...
Identification of MHC class I–bound peptides by immunopurification of MHC complexes and subsequent a...
Effective immunotherapies rely on specific activation of immune cells. Class I major histocompatibil...
© 2012 Dr. Chor Teck TanThe immune system constantly samples the cellular proteome through the proce...
Peptide antigens bound to molecules encoded by the major histocompatibility complex (MHC) and presen...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
Mass spectrometric approaches have recently gained increasing access to molecular immunology and sev...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
The magnitude of T cell responses to infection is a function of the naïve T cell repertoire combined...
Major histocompatibility complexes (MHC) play a critical role in immunity by presenting peptides on ...
We describe the application of immunoaffinity extraction and mass spectrometry to the analysis of Ty...
Major histocompatibility complex class II (MHC II) molecules are expressed on the surface of antigen...
Peptide major histocompatibility complex (pMHC) multimers have been used since decades to identify, ...
Major histocompatibility complex (MHC) class II antigen presentation is a key component in eliciting...
Antigen presentation by MHC-II proteins in the thymus is central to selection of CD4 T cells, but an...
Identification of MHC class I–bound peptides by immunopurification of MHC complexes and subsequent a...
Effective immunotherapies rely on specific activation of immune cells. Class I major histocompatibil...
© 2012 Dr. Chor Teck TanThe immune system constantly samples the cellular proteome through the proce...
Peptide antigens bound to molecules encoded by the major histocompatibility complex (MHC) and presen...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
Mass spectrometric approaches have recently gained increasing access to molecular immunology and sev...
The mammalian immune system has evolved to display fragments of protein antigens derived from microb...
The magnitude of T cell responses to infection is a function of the naïve T cell repertoire combined...
Major histocompatibility complexes (MHC) play a critical role in immunity by presenting peptides on ...
We describe the application of immunoaffinity extraction and mass spectrometry to the analysis of Ty...
Major histocompatibility complex class II (MHC II) molecules are expressed on the surface of antigen...
Peptide major histocompatibility complex (pMHC) multimers have been used since decades to identify, ...
Major histocompatibility complex (MHC) class II antigen presentation is a key component in eliciting...
Antigen presentation by MHC-II proteins in the thymus is central to selection of CD4 T cells, but an...
Identification of MHC class I–bound peptides by immunopurification of MHC complexes and subsequent a...
Effective immunotherapies rely on specific activation of immune cells. Class I major histocompatibil...